Knee Joint Biologic Injections in West Valley City, UT

What I’d check before adding knee joint biologic injections here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 10.6% of adults in West Valley City have diagnosed diabetes — 1.4 points below the U.S. 12% figure. 19.8% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick knee joint biologic injections against that mix.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 20.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 19.8% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Utah.
• City-proper population of 140,230 is a Census figure, not a clinic count. It tells you the size of the catchment, not how many biologic vendors already call on the orthopedic group down the street.
• Noridian Healthcare Solutions LCDs often require serial wound measurements, debridement notes, and conservative-care history before CTPs. Clinics in Utah that buy product without a documentation template burn the first 90 days on recoupments.

Payer geography for West Valley City, UT

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in West Valley City is 10.6% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic